Addus HomeCare Corporation $ADUS Shares Newly Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. purchased a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the third quarter, HoldingsChannel reports. The institutional investor purchased 11,523 shares of the company’s stock, valued at approximately $1,274,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Hsbc Holdings PLC raised its holdings in shares of Addus HomeCare by 73.3% in the 2nd quarter. Hsbc Holdings PLC now owns 24,463 shares of the company’s stock worth $2,446,000 after buying an additional 10,350 shares in the last quarter. Summit Creek Advisors LLC bought a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $8,552,000. Globeflex Capital L P bought a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $1,635,000. Bank of America Corp DE boosted its stake in Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after buying an additional 32,714 shares in the last quarter. Finally, The Manufacturers Life Insurance Company acquired a new stake in Addus HomeCare in the 2nd quarter valued at $901,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP David Tucker sold 14,850 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $124.75, for a total value of $1,852,537.50. Following the transaction, the executive vice president directly owned 8,073 shares of the company’s stock, valued at $1,007,106.75. The trade was a 64.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Allison sold 98,958 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $123.27, for a total value of $12,198,552.66. Following the sale, the chief executive officer owned 183,150 shares in the company, valued at approximately $22,576,900.50. This trade represents a 35.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 141,894 shares of company stock worth $17,536,266 over the last ninety days. 4.10% of the stock is owned by insiders.

Addus HomeCare Price Performance

NASDAQ:ADUS traded down $0.72 on Friday, reaching $123.00. The stock had a trading volume of 105,094 shares, compared to its average volume of 256,876. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $2.29 billion, a P/E ratio of 20.50, a price-to-earnings-growth ratio of 1.63 and a beta of 0.75. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $131.59. The stock has a fifty day moving average price of $118.39 and a 200-day moving average price of $107.25.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The company’s revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the business posted $1.56 earnings per share. Research analysts forecast that Addus HomeCare Corporation will post 6.41 EPS for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Weiss Ratings upgraded Addus HomeCare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Truist Financial increased their price objective on Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Royal Bank Of Canada lifted their price objective on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Zacks Research raised Addus HomeCare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, November 10th. Finally, Raymond James Financial set a $137.00 target price on shares of Addus HomeCare in a research note on Monday, September 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $136.33.

About Addus HomeCare

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.